Val Gebski
0000-0001-8748-1844
Publication & Citation Trends
Publications
0 total
Under the radar—frequency, timing, duration, and trajectory of lower-grade adverse events in clinical trials of anti-cancer therapies
Cited by 0
Semantic Scholar
1814 Cost comparison of silicone-based skin care with Mepitel® versus StrataXRT®: a prospective randomised controlled trial in post-mastectomy radiotherapy
Cited by 0
Semantic Scholar
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy.
Cited by 2
Semantic Scholar
Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy
Cited by 6
Semantic Scholar
Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Cited by 18
Semantic Scholar
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer.
Cited by 0
Semantic Scholar
2174: Single versus multi-fraction SABR for early-stage primary lung and pulmonary oligometastases.
Cited by 0
Semantic Scholar
Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study.
Cited by 44
Semantic Scholar
Research Topics
Ovarian cancer diagnosis and treatment
(81)
Endometrial and Cervical Cancer Treatments
(73)
Colorectal Cancer Treatments and Studies
(62)
Pancreatic and Hepatic Oncology Research
(58)
Gastric Cancer Management and Outcomes
(57)
Affiliations
Linköping University
South Australia Pathology
University of Technology Sydney
University of Southern California
Roche (Switzerland)